COP
47
2
VLO
28
2
BF.B
53
2
MET
47
-6
QCOM
80
9
DGX
44
-4
KMI
50
6
MPC
30
-9
TRIP
73
7
MMM
30
-5
RRC
65
3
PH
67
-3
FCX
52
-4
GOOG
89
2
K
51
10
CI
52
-14
VMC
74
2
MCO
73
2
GME
74
12
AVB
69
4
COP
47
2
VLO
28
2
BF.B
53
2
MET
47
-6
QCOM
80
9
DGX
44
-4
KMI
50
6
MPC
30
-9
TRIP
73
7
MMM
30
-5
RRC
65
3
PH
67
-3
FCX
52
-4
GOOG
89
2
K
51
10
CI
52
-14
VMC
74
2
MCO
73
2
GME
74
12
AVB
69
4
Financhill
Back

Regencell Bioscience Holdings 10K Form

Buy
52

RGC
Regencell Bioscience Holdings

Last Price:
5.10
Seasonality Move:
6.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RGC News And Ratings

See the #1 stock for the next 7 days that we like better than RGC

RGC Financial Statistics

Sales & Book Value

Annual Sales: $3.16B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.92
Price / Book: 0

Profitability

EPS (TTM): -0.45000
Net Income (TTM): $-5.87M
Gross Margin: $1.97B
Return on Equity: 0%
Return on Assets: 0%

Regencell Bioscience Holdings Earnings Forecast

Key Regencell Bioscience Holdings Financial Ratios

  • The Gross Profit Margin over the past 13 years for RGC is 62.33%.
  • The Selling, General & Administrative Expenses for RGC have been equal to 16.23% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 18 years have been positive in 7 years.

Regencell Bioscience Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RGC
Website: regencellbioscience.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RGC Technical Analysis vs Fundamental Analysis

Buy
52
Regencell Bioscience Holdings (RGC) is a Buy

Is Regencell Bioscience Holdings a Buy or a Sell?